Biopharmx Corp (NYSEAMERICAN:BPMX) shares shot up 20% during mid-day trading on Monday . The stock traded as high as $0.12 and last traded at $0.12. 11,507,897 shares were traded during mid-day trading, an increase of 149% from the average session volume of 4,622,910 shares. The stock had previously closed at $0.10.
Biopharmx (NYSEAMERICAN:BPMX) last announced its quarterly earnings results on Thursday, March 14th. The biotechnology company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.01. The company had revenue of $0.01 million for the quarter.
ILLEGAL ACTIVITY NOTICE: This article was reported by Zolmax and is the sole property of of Zolmax. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://zolmax.com/investing/biopharmx-bpmx-shares-up-20/2973020.html.
Biopharmx Company Profile (NYSEAMERICAN:BPMX)
BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC).
See Also: Average Daily Trade Volume – ADTV
Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with MarketBeat.com's FREE daily email newsletter.